Types of cystic neoplasms
Main types of cystic tumors detected on diagnostic imaging:
- Serous cystadenoma (Serous Cystadenoma). Typically located in the head of the pancreas. On MRI (T2-weighted images), it appears as a microcystic lesion—a "sponge" of numerous small cysts (only occasional ones may be large). Following gadolinium administration (T1WI), the septa and the characteristic central scar enhance with contrast. The absence of other solid components confirms its benign nature.
- Mucinous cystadenocarcinoma (Mucinous Cystadenocarcinoma). A malignant tumor. Most commonly affects the tail. On contrast-enhanced CT, it is defined as a cystic mass with a thick, irregular wall. The lesion can be large, of mixed structure (cysts + solid component), and closely apposed to the celiac trunk and common hepatic artery. Frequently metastasizes to the liver (cystic or large exophytic metastases).
- Intraductal papillary mucinous neoplasms (IPMN / IPMN). Divided into branch-duct type, mixed type, and main-duct type. The main diagnostic sign is the communication of the cyst with the pancreatic duct. Volume rendering and minimum intensity projection (MinIP) techniques on MSCT, as well as MRCP, are excellent for visualizing this connection. The presence of solid nodules within the lumen is a sign of potential malignant transformation.
IPMN: High-risk and worrisome features
According to the Fukuoka Guidelines, the management of IPMN depends on the radiological findings.
Worrisome features (require endoscopic ultrasound for further evaluation):
- Cyst size ≥ 3 cm.
- Enhancing mural nodules (mural nodules) < 5 mm.
- Thickened, contrast-enhancing cyst wall.
- Main pancreatic duct (MPD) dilatation of 5–9 mm.
- Abrupt duct narrowing with distal pancreatic atrophy.
- Enlarged lymph nodes (lymphadenopathy).
- Rapid growth (more than 5 mm over 2 years).
High-risk stigmata (direct indication for surgery):
- Development of obstructive jaundice (when located in the head).
- Enhancing solid nodule ≥ 5 mm.
- Main pancreatic duct dilatation ≥ 10 mm.
Reliable CT signs of already established malignant transformation in IPMN include a solid infiltrative component and encasement (sleeplike wrapping) of the superior mesenteric artery and vein.
Differential diagnosis and pseudotumors
Not all cystic lesions are true neoplasms. Fluid analysis obtained via fine-needle aspiration (FNA) is essential for an accurate diagnosis.
- A high amylase level in the aspirate is characteristic of a pseudocyst.
- An elevated carcinoembryonic antigen (CEA) level indicates a mucinous tumor.
Conditions that mimic a tumor on imaging include:
- Inflammatory pseudotumors in chronic or paraduodenal pancreatitis.
- Focal fatty infiltration. Demonstrates low attenuation on CT. Chemical-shift MRI helps distinguish it.
- Lipoma. Easily mistaken for a cyst if CT attenuation is not measured.
Systemic diseases associated with pancreatic cysts
Pancreatic cysts can be a manifestation of genetic and systemic conditions:
- Cystic fibrosis. Thick secretions block the ducts, leading to cyst formation, parenchymal fat replacement, and calcifications.
- Autosomal dominant polycystic kidney disease (ADPKD). In 10% of patients, the pancreas is affected alongside the kidneys.
- Von Hippel-Lindau disease. Characterized by the formation of simple pancreatic cysts, and less commonly, serous cystadenomas and neuroendocrine tumors.
Briefly: answers to topical questions
Which MRI sequences are included in the standard protocol for investigating pancreatic cystic lesions?
A strict standard protocol is not described in the sources, but the following MRI sequences are used to evaluate pancreatic cystic lesions.
- T2-weighted turbo spin-echo (T2-weighted TSE) — used to visualize the structure (e.g., microcystic mass) and location of the lesion.
- T1-weighted gradient echo (T1-weighted GRE) with gadolinium contrast enhancement — used to assess contrast enhancement of septa and the central scar, and to detect solid components.
- Magnetic resonance cholangiopancreatography (MRCP) — essential for identifying the connection between the lesion and the ductal system and assessing main pancreatic duct dilatation.
Class and exam questions
What is the main difference between a branch-duct IPMN and other cysts?
A pathognomonic sign of branch-duct IPMN is the presence of communication between the cystic lesion and an unchanged main pancreatic duct. This is best visualized on MRCP or MinIP reconstructions.
What should be done with small incidental cysts (up to 3 cm) without symptoms?
If there are no worrisome features (MPD dilatation, thickened walls, solid nodules), serial imaging follow-up (CT or MRI) is permissible.
How to differentiate a benign serous cystadenoma from a malignant mucinous one?
Serous cystadenoma is typically microcystic, features a central scar, lacks additional solid components, and is located in the head. Mucinous cystadenocarcinoma has thick walls, a mixed solid-cystic structure, frequently grows in the tail, and invades vessels.
What else to study on this topic
- Metastatic involvement of the pancreas (in RCC, melanoma)
- Rare neoplasms (pancreatoblastoma, solid-pseudopapillary neoplasm)
- Osler-Weber-Rendu disease and angiographic findings of the pancreas
- Chemical-shift MRI protocol for assessing fatty infiltration
- The role of EUS with fine-needle aspiration in indeterminate cysts
Master the entire topic in the "Diagnostic Radiology" course
This is a summary. The course covers everything tested in classes and exams.
- Comprehensive guideline on "Pancreatic Cystic Lesions" and 2,199 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 10 video lessons on the subject
Other topics in the section "Diagnostic Radiology of the Abdominal Organs"
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.